ADHD associated_with 23andMe
Evidence from:
primary |
all sources
Evidence (3 sources)
Guidelines for Evaluating the Comparability of Down-Sampled GWAS Summary Statistics.
(2023)
PMID:37713023
primary
Summary of GWAS summary statistics with and without 23andMe data for seven externalizing-related disorders and behaviors
confidence: 0.96
Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder.
(2019)
PMID:30478444
cited
a GWAS of self-reported ADHD status among 23andMe research participants (5,857 cases, 70,393 controls)
confidence: 0.96
Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder.
(2019)
PMID:30478444
cited
Regressing effect size estimates from 23andMe on ADHD GWAS yields a positive slope (0.417, P = 1.11 × 10⁻³).
confidence: 0.94